Replies to post #2207610 on MOMO'S BREAKOUT BOARD

[Atlanta1]

$MDXG

guys - this $31 price target was BEFORE the Pfizer/Lilly failure and BEFORE the "multiple buyout offers" language.

DECEMBER 16, 2020
MIMEDX GROUP INC. | MDXG – UPDATE
We are raising our price target on MiMedx Group to $31 per share based on extensive new research showing that MiMedx’s Amniofix treatment will be a blockbuster for knee OA

https://www.presciencepoint.com/research/research-archives/mimedx-group-inc-mdxg-update/